If you frequently struggle with weight loss, you may be a good candidate for Semaglutide in New York City, Long Island, and New Jersey. Semaglutide, the brand name Wegovy, is an injectable prescription medication for obese adults and teenagers. It is in the class of drugs called GLP-1 receptor agonists, a synthetic version of a naturally occurring hormone called GLP-1.
How Soon Can I Expect to Lose Weight with Semaglutide?
When you start taking Semaglutide in NYC, Long Island, and New Jersey, the first four to twelve weeks are known as the induction phase. During this period, you'll gradually increase your dose to help your body adjust to the medication. After the induction phase, you enter the maintenance phase, when you can typically expect to begin losing weight.